Actinogen Medical Limited ACN 086 778 476 Suite 901, Level 9, 109 Pitt Street, Sydney NSW 2000 +61 2 8964 7401 | actinogen.com.au 1 Cleansing Notice – Options Underwriting Sydney, 23 September 2026: Actinogen Medical ASX: ACW (“ACW” or “the Company”) announced today that it has...
Options underwriting cleansing notice
Filed with ASX · · 2 pages · English
Release
Actinogen Medical Limited on 6ix
Earlier from Actinogen Medical
- Application for quotation of securities - ACW
- ACW Alzheimers pivotal trial completes last patient visit
- Notification of cessation of securities - ACW
- Appendix 3Y-Dr Geoffrey Brooke
- ACW CMO international Xanamem presentation
Later from Actinogen Medical
- Underwriting of unlisted options completed
- Actinogen XanaMIA pivotal Alzheimer’s disease trial completes final patient visit, with topline results on track for November
- AGM date and closing date for director nominations
- Notification of buy-back - ACW
- ACW September 2026 quarterly activity report & Appendix 4C
Follow Actinogen Medical into a list and get an email when it puts out news.
Follow Actinogen Medical